You may have heard that Amgen, which manufactures the cholesterol-lowering drug evolocumab (Repatha), just announced it is lowering the list price of the drug by about 60 percent to $5,850 per year from its original list price of $14,523. The company says that the goal of the price drop is to help lower patients’ copays, […]
New York State Proclaims June as Migraine Awareness Month.
The U.S. Food and Drug Administration announced the approval of a new preventive migraine treatment.
Advocating for collective health issues may help you pursue your own care, fuel well-being, and more. https://www.everydayhealth.com/rheumatoid-arthritis/living-with/rheumatoid-arthritis-activism-produces-resilience/
Seth Ginsberg, co-founder and president of the Global Healthy Living Foundation, explains what patients should know about biosimilar therapies. http://www.centerforbiosimilars.com/interviews/seth-ginsberg-what-patients-need-to-know-about-biosimilars